| Year |
Citation |
Score |
| 2022 |
Swetha KL, Maravajjala KS, Li SD, Singh MS, Roy A. Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation. Drug Delivery and Translational Research. PMID 35697894 DOI: 10.1007/s13346-022-01194-7 |
0.371 |
|
| 2022 |
Nguyen A, Rouhollahi E, Böttger R, Ong CY, Chao PH, Wu J, Chen Y, Li SD. Interplay between the linker and polymer molecular weight of a self-assembling prodrug on the pharmacokinetics and therapeutic efficacy. Biomaterials Science. PMID 35544350 DOI: 10.1039/d1bm01947c |
0.306 |
|
| 2020 |
Nguyen A, Ando H, Böttger R, DurgaRao Viswanadham KK, Rouhollahi E, Ishida T, Li SD. Utilization of click chemistry to study the effect of poly(ethylene)glycol molecular weight on the self-assembly of PEGylated gambogic acid nanoparticles for the treatment of rheumatoid arthritis. Biomaterials Science. PMID 32700691 DOI: 10.1039/D0Bm00711K |
0.386 |
|
| 2020 |
Böttger R, Pauli G, Chao PH, Al-Fayez N, Hohenwarter L, Li SD. Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews. PMID 32574575 DOI: 10.1016/J.Addr.2020.06.017 |
0.381 |
|
| 2019 |
Pauli G, Tang WL, Li SD. Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds. Pharmaceutics. 11. PMID 31505795 DOI: 10.3390/Pharmaceutics11090465 |
0.321 |
|
| 2019 |
Zhang W, Böttger R, Qin Z, Kulkarni JA, Vogler J, Cullis PR, Li SD. Phospholipid-Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver. Small (Weinheim An Der Bergstrasse, Germany). e1901782. PMID 31490617 DOI: 10.1002/Smll.201901782 |
0.39 |
|
| 2019 |
Hamano N, Böttger R, Lee SE, Yang Y, Kulkarni JA, Ip S, Cullis PR, Li SD. A robust microfluidic technology and a new lipid composition for fabrication of curcumin-loaded liposomes: Effect on the anticancer activity and safety of cisplatin. Molecular Pharmaceutics. PMID 31381352 DOI: 10.1021/Acs.Molpharmaceut.9B00583 |
0.424 |
|
| 2018 |
Mahjub R, Jatana S, Lee SE, Qin Z, Pauli G, Soleimani M, Madadi S, Li SD. Recent advances in applying nanotechnologies for cancer immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30223043 DOI: 10.1016/J.Jconrel.2018.09.010 |
0.414 |
|
| 2018 |
Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Ajazuddin, Alexander A. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opinion On Drug Delivery. PMID 29733231 DOI: 10.1080/17425247.2018.1471058 |
0.336 |
|
| 2018 |
Tang WL, Tang WH, Li SD. Cancer theranostic applications of lipid-based nanoparticles. Drug Discovery Today. PMID 29660478 DOI: 10.1016/J.Drudis.2018.04.007 |
0.368 |
|
| 2018 |
Tang WL, Tang WH, Szeitz A, Kulkarni J, Cullis P, Li SD. Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery. Biomaterials. 166: 13-26. PMID 29529479 DOI: 10.1016/J.Biomaterials.2018.03.004 |
0.397 |
|
| 2018 |
Li SD. A celebration of Professor Leaf Huang's contribution to the field of drug delivery and his lifetime achievement award. Journal of Drug Targeting. 1-3. PMID 29455560 DOI: 10.1080/1061186X.2018.1440924 |
0.312 |
|
| 2018 |
Ho L, Bokharaei M, Li SD. Current update of a thermosensitive liposomes composed of DPPC and Brij78. Journal of Drug Targeting. 1-41. PMID 29325469 DOI: 10.1080/1061186X.2017.1419361 |
0.426 |
|
| 2017 |
Chih-Chun C, Yang Y, Gao DY, Cheng HT, Hoang B, Chao PH, Chen LH, Bteich J, Chiang T, Liu JY, Li SD, Chen Y. Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in Mice. Journal of Drug Targeting. 1-27. PMID 29251522 DOI: 10.1080/1061186X.2017.1419358 |
0.507 |
|
| 2017 |
Hoang B, Ernsting MJ, Tang WS, Bteich J, Undzys E, Kiyota T, Li SD. Cabazitaxel-Conjugated Nanoparticles for Docetaxel-Resistant and Bone Metastatic Prostate Cancer. Cancer Letters. PMID 28965854 DOI: 10.1016/J.Canlet.2017.09.029 |
0.355 |
|
| 2017 |
Roy A, Zhao Y, Yang Y, Szeitz A, Klassen T, Li SD. Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle. Biomaterials. 137: 11-22. PMID 28528299 DOI: 10.1016/J.Biomaterials.2017.05.019 |
0.459 |
|
| 2017 |
Tang WL, Tang WS, Chen WC, Diako C, Ross CF, Li SD. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes. Molecular Pharmaceutics. PMID 28460165 DOI: 10.1021/Acs.Molpharmaceut.7B00077 |
0.347 |
|
| 2017 |
Yang Y, Roy A, Zhao Y, Undzys E, Li SD. Comparison of tumor penetration of podophyllotoxin-carboxymethylcellulose conjugates with various chemical compositions in tumor spheroid culture and in vivo solid tumor. Bioconjugate Chemistry. PMID 28437080 DOI: 10.1021/Acs.Bioconjchem.7B00165 |
0.45 |
|
| 2017 |
Hysi E, Wirtzfeld LA, May JP, Undzys E, Li SD, Kolios MC. Photoacoustic signal characterization of cancer treatment response: Correlation with changes in tumor oxygenation. Photoacoustics. 5: 25-35. PMID 28393017 DOI: 10.1016/J.Pacs.2017.03.003 |
0.336 |
|
| 2016 |
Yang Y, Bteich J, Li SD. Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors. The Aaps Journal. PMID 27873118 DOI: 10.1208/S12248-016-0014-Z |
0.468 |
|
| 2016 |
May JP, Hysi E, Wirtzfeld LA, Undzys E, Li SD, Kolios MC. Photoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive Liposomes. Plos One. 11: e0165345. PMID 27788199 DOI: 10.1371/Journal.Pone.0165345 |
0.371 |
|
| 2016 |
Hu B, Zhang K, Li S, Li H, Yan Z, Huang L, Wu J, Han X, Jiang W, Mulatibieke T, Zheng L, Wan R, Wang X, Hu G. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer. Cancer Letters. PMID 27085461 DOI: 10.1016/j.canlet.2016.04.013 |
0.368 |
|
| 2016 |
Roy A, Li SD. Modifying the tumor microenvironment using nanoparticle therapeutics. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 27038329 DOI: 10.1002/Wnan.1406 |
0.439 |
|
| 2016 |
Li S, Fang C, Zhang J, Liu B, Wei Z, Fan X, Sui Z, Tan Q. Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 26995093 DOI: 10.1016/j.nano.2016.02.007 |
0.309 |
|
| 2016 |
Tang WL, Chen WC, Roy A, Undzys E, Li SD. A Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer. Pharmaceutical Research. PMID 26758590 DOI: 10.1007/S11095-015-1854-4 |
0.44 |
|
| 2016 |
Bteich J, Hoang B, Undzys E, Mohammed M, Su AL, Ou K, Emerson D, Sokoll K, Li S, Trikha M, Lowman H, Ernsting MJ. Abstract 1342: A production-scalable cabazitaxel cellulose nanoparticle exhibits significant efficacy in a bone model of docetaxel-resistant prostate cancer Cancer Research. 76: 1342-1342. DOI: 10.1158/1538-7445.Am2016-1342 |
0.324 |
|
| 2016 |
Hysi E, May JP, Wirtzfeld L, Undzys E, Li S, Kolios MC. Monitoring cancer treatment response using photoacoustic and ultrasound spectral analysis in combination with oxygenation measurements (Conference Presentation) Proceedings of Spie. 9708: 970824. DOI: 10.1117/12.2213596 |
0.314 |
|
| 2015 |
May J, Undzys E, Roy A, Li SD. Synthesis of a gemcitabine pro-drug for remote loading into liposomes and improved therapeutic effect. Bioconjugate Chemistry. PMID 26673036 DOI: 10.1021/Acs.Bioconjchem.5B00619 |
0.375 |
|
| 2015 |
Li S, Chen SJ, Chen Y. An ab initio investigation on the ground electronic state of chlorine monoxide and its singly charged cation and anion. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 152: 453-460. PMID 26247329 DOI: 10.1016/j.saa.2015.07.100 |
0.448 |
|
| 2015 |
Zhao Y, May JP, Chen IW, Undzys E, Li SD. A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor. Pharmaceutical Research. 32: 3261-8. PMID 25964047 DOI: 10.1007/S11095-015-1702-6 |
0.405 |
|
| 2015 |
Hoang B, Ernsting MJ, Roy A, Murakami M, Undzys E, Li SD. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism. Biomaterials. 59: 66-76. PMID 25956852 DOI: 10.1016/J.Biomaterials.2015.04.032 |
0.431 |
|
| 2015 |
Roy A, Ernsting MJ, Undzys E, Li SD. A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors. Biomaterials. 52: 335-46. PMID 25818440 DOI: 10.1016/J.Biomaterials.2015.02.041 |
0.449 |
|
| 2015 |
Ernsting MJ, Hoang B, Lohse I, Undzys E, Cao P, Do T, Gill B, Pintilie M, Hedley D, Li SD. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. Journal of Controlled Release : Official Journal of the Controlled Release Society. 206: 122-30. PMID 25804872 DOI: 10.1016/J.Jconrel.2015.03.023 |
0.437 |
|
| 2015 |
Hysi E, May JP, Writzfeld L, Undyzs E, Li SD, Kolios MC. Probing the in vivo changes in oxygen saturation with photoacoustic imaging as a non-invasive means of assessing treatment progression Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9323. DOI: 10.1117/12.2080372 |
0.382 |
|
| 2014 |
Hoang B, Ernsting MJ, Murakami M, Undzys E, Li SD. Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer. International Journal of Pharmaceutics. 471: 224-33. PMID 24853460 DOI: 10.1016/J.Ijpharm.2014.05.021 |
0.412 |
|
| 2014 |
Roy A, Bhattacharyya M, Ernsting MJ, May JP, Li SD. Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxel. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 349-68. PMID 24652678 DOI: 10.1002/Wnan.1264 |
0.339 |
|
| 2014 |
Roy A, Murakami M, Ernsting MJ, Hoang B, Undzys E, Li SD. Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance. Molecular Pharmaceutics. 11: 2592-9. PMID 24564177 DOI: 10.1021/Mp400643P |
0.413 |
|
| 2014 |
May JP, Hysi E, Wirtzfeld L, Undzys E, Kolios MC, Li S. Abstract LB-165: Early detection of the therapeutic effect in tumors treated with a thermosensitive liposome (TSL) using noninvasive ultrasound and photoacoustic imaging Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-165 |
0.423 |
|
| 2014 |
Ernsting M, Murakami M, Undzys E, Li S. Abstract 4486: Stromal depletion by a docetaxel nanoparticle for enhanced therapy of breast and pancreatic cancer Cancer Research. 74: 4486-4486. DOI: 10.1158/1538-7445.Am2014-4486 |
0.447 |
|
| 2013 |
May JP, Ernsting MJ, Undzys E, Li SD. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. Molecular Pharmaceutics. 10: 4499-508. PMID 24152292 DOI: 10.1021/Mp400321E |
0.424 |
|
| 2013 |
Ernsting MJ, Murakami M, Roy A, Li SD. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 782-94. PMID 24075927 DOI: 10.1016/J.Jconrel.2013.09.013 |
0.462 |
|
| 2013 |
Murakami M, Ernsting MJ, Undzys E, Holwell N, Foltz WD, Li SD. Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis. Cancer Research. 73: 4862-71. PMID 23907638 DOI: 10.1158/0008-5472.Can-13-0062 |
0.447 |
|
| 2013 |
May JP, Li SD. Hyperthermia-induced drug targeting. Expert Opinion On Drug Delivery. 10: 511-27. PMID 23289519 DOI: 10.1517/17425247.2013.758631 |
0.401 |
|
| 2013 |
Chen WC, May JP, Li SD. Immune responses of therapeutic lipid nanoparticles Nanotechnology Reviews. 2: 201-213. DOI: 10.1515/Ntrev-2012-0040 |
0.353 |
|
| 2012 |
Ernsting MJ, Murakami M, Undzys E, Aman A, Press B, Li SD. A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases. Journal of Controlled Release : Official Journal of the Controlled Release Society. 162: 575-81. PMID 22967490 DOI: 10.1016/J.Jconrel.2012.07.043 |
0.466 |
|
| 2012 |
Tagami T, May JP, Ernsting MJ, Li SD. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 142-9. PMID 22504351 DOI: 10.1016/J.Jconrel.2012.03.023 |
0.387 |
|
| 2012 |
Ernsting MJ, Foltz WD, Undzys E, Tagami T, Li SD. Tumor-targeted drug delivery using MR-contrasted docetaxel - carboxymethylcellulose nanoparticles. Biomaterials. 33: 3931-41. PMID 22369962 DOI: 10.1016/J.Biomaterials.2012.02.019 |
0.442 |
|
| 2012 |
Ernsting MJ, Tang WL, MacCallum NW, Li SD. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models. Biomaterials. 33: 1445-54. PMID 22079003 DOI: 10.1016/J.Biomaterials.2011.10.061 |
0.423 |
|
| 2012 |
Chen WC, Zhang AX, Li SD. Limitations and niches of the active targeting approach for nanoparticle drug delivery European Journal of Nanomedicine. 4: 89-93. DOI: 10.1515/Ejnm-2012-0010 |
0.457 |
|
| 2011 |
Ernsting MJ, Tang WL, MacCallum N, Li SD. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells. Bioconjugate Chemistry. 22: 2474-86. PMID 22014112 DOI: 10.1021/Bc200284B |
0.439 |
|
| 2011 |
Tagami T, Foltz WD, Ernsting MJ, Lee CM, Tannock IF, May JP, Li SD. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials. 32: 6570-8. PMID 21641639 DOI: 10.1016/J.Biomaterials.2011.05.029 |
0.401 |
|
| 2011 |
Tagami T, Ernsting MJ, Li SD. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. Journal of Controlled Release : Official Journal of the Controlled Release Society. 154: 290-7. PMID 21640149 DOI: 10.1016/J.Jconrel.2011.05.020 |
0.348 |
|
| 2011 |
Tagami T, Ernsting MJ, Li SD. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. Journal of Controlled Release : Official Journal of the Controlled Release Society. 152: 303-9. PMID 21338635 DOI: 10.1016/J.Jconrel.2011.02.009 |
0.454 |
|
| 2010 |
Bauman JA, Li SD, Yang A, Huang L, Kole R. Anti-tumor activity of splice-switching oligonucleotides. Nucleic Acids Research. 38: 8348-56. PMID 20719743 DOI: 10.1093/Nar/Gkq731 |
0.444 |
|
| 2010 |
Li SD, Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. Journal of Controlled Release : Official Journal of the Controlled Release Society. 145: 178-81. PMID 20338200 DOI: 10.1016/j.jconrel.2010.03.016 |
0.488 |
|
| 2010 |
Li SD, Howell SB. CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases. Molecular Pharmaceutics. 7: 280-90. PMID 19994852 DOI: 10.1021/Mp900242F |
0.345 |
|
| 2009 |
Li SD, Huang L. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochimica Et Biophysica Acta. 1788: 2259-66. PMID 19595666 DOI: 10.1016/j.bbamem.2009.06.022 |
0.454 |
|
| 2008 |
Li SD, Huang L. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances. Current Opinion in Investigational Drugs (London, England : 2000). 9: 1317-23. PMID 19037838 |
0.476 |
|
| 2008 |
Chono S, Li SD, Conwell CC, Huang L. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. Journal of Controlled Release : Official Journal of the Controlled Release Society. 131: 64-9. PMID 18674578 DOI: 10.1016/j.jconrel.2008.07.006 |
0.51 |
|
| 2008 |
Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Molecular Pharmaceutics. 5: 496-504. PMID 18611037 DOI: 10.1021/Mp800049W |
0.476 |
|
| 2008 |
Li SD, Chono S, Huang L. Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 942-6. PMID 18388916 DOI: 10.1038/mt.2008.51 |
0.475 |
|
| 2008 |
Li SD, Chono S, Huang L. Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 126: 77-84. PMID 18083264 DOI: 10.1016/j.jconrel.2007.11.002 |
0.483 |
|
| 2008 |
Li SD, Chen YC, Hackett MJ, Huang L. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 163-9. PMID 17923843 DOI: 10.1038/Sj.Mt.6300323 |
0.638 |
|
| 2007 |
Li SD, Huang L. Non-viral is superior to viral gene delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 123: 181-3. PMID 17935817 DOI: 10.1016/j.jconrel.2007.09.004 |
0.36 |
|
| 2006 |
Li SD, Huang L. Surface-modified LPD nanoparticles for tumor targeting. Annals of the New York Academy of Sciences. 1082: 1-8. PMID 17145918 DOI: 10.1196/annals.1348.001 |
0.51 |
|
| 2006 |
Li SD, Huang L. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Molecular Pharmaceutics. 3: 579-88. PMID 17009857 DOI: 10.1021/mp060039w |
0.521 |
|
| 2006 |
Li SD, Huang L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Therapy. 13: 1313-9. PMID 16953249 DOI: 10.1038/sj.gt.3302838 |
0.428 |
|
| 2006 |
Li S, Huang L. 715. Targeted Delivery of Antisense Oligonucleotide and siRNA into Lung Cancer Cells Molecular Therapy. 13: S276. DOI: 10.1016/J.Ymthe.2006.08.794 |
0.478 |
|
| 1999 |
Whitmore M, Li S, Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Therapy. 6: 1867-1875. PMID 10602382 DOI: 10.1038/Sj.Gt.3301026 |
0.502 |
|
| 1997 |
Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes Gene Therapy. 4: 891-900. PMID 9349425 DOI: 10.1038/Sj.Gt.3300482 |
0.452 |
|
| Show low-probability matches. |